260 related articles for article (PubMed ID: 24246920)
1. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
[TBL] [Abstract][Full Text] [Related]
3. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.
Sang W; Zhang W; Cui W; Li X; Abulajiang G; Li Q
Tumour Biol; 2015 May; 36(5):3881-6. PubMed ID: 25577247
[TBL] [Abstract][Full Text] [Related]
4. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
Chandan VS; Shah SS; Torbenson MS; Wu TT
Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
6. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
7. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
[TBL] [Abstract][Full Text] [Related]
8. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
Timek DT; Shi J; Liu H; Lin F
Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
Atta IS
Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver.
Labib OH; Harb OA; Khalil OH; Baiomy TA; Gertallah LM; Ahmed RZ
J Gastrointest Cancer; 2020 Mar; 51(1):88-101. PubMed ID: 30784016
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver.
Geramizadeh B; Seirfar N
Hepat Mon; 2015 Jul; 15(7):e30336. PubMed ID: 26300935
[TBL] [Abstract][Full Text] [Related]
12. Well differentiated arginase-1 negative hepatocellular carcinoma.
Obiorah IE; Chahine J; Park BU; Ko K; deGuzman J; Kallakury B
Transl Gastroenterol Hepatol; 2019; 4():66. PubMed ID: 31620648
[TBL] [Abstract][Full Text] [Related]
13. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
Fujiwara M; Kwok S; Yano H; Pai RK
Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
[TBL] [Abstract][Full Text] [Related]
14. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
Fan Z; van de Rijn M; Montgomery K; Rouse RV
Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966
[TBL] [Abstract][Full Text] [Related]
15. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
McKnight R; Nassar A; Cohen C; Siddiqui MT
Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
[TBL] [Abstract][Full Text] [Related]
16. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
[TBL] [Abstract][Full Text] [Related]
17. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
Clark I; Shah SS; Moreira R; Graham RP; Wu TT; Torbenson MS; Chandan V
Hum Pathol; 2017 Nov; 69():90-95. PubMed ID: 28970136
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
Ibrahim TR; Abdel-Raouf SM
Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
[TBL] [Abstract][Full Text] [Related]
19. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
Fatima N; Cohen C; Siddiqui MT
Acta Cytol; 2014; 58(1):83-8. PubMed ID: 24281232
[TBL] [Abstract][Full Text] [Related]
20. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
Zhao CL; Hui Y; Wang LJ; Yang D; Yakirevich E; Mangray S; Huang CK; Lu S
Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]